This antibody targets the prodomain of PCSK9 and can be potentially used in treatment of cholesterol-related disorders.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1775z | Mouse Anti-PCSK9 Recombinant Antibody (clone 40B4) | WB, ELISA, IF, IP | Mouse IgG1, κ |
PABL-294 | Human Anti-PCSK9 Recombinant Antibody (clone mAb1) | WB, Block, FuncS | Human IgG |
PABL-676 | Human Anti-PCSK9 Recombinant Antibody (PABL-676) | WB, FuncS | Human IgG |
PABL-677 | Mouse Anti-PCSK9 Recombinant Antibody (clone mAb J16) | WB, ELISA, FuncS | Mouse IgG |
PABL-678 | Human Anti-PCSK9 Recombinant Antibody (clone CBL21Q) | ELISA, WB | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
NABL-097 | Recombinant Anti-human PCSK9 VHH Single Domain Antibody | WB, ELISA, IHC, FC, FuncS | Llama VHH |
TAB-0080CL-VHH | Anti-Human PCSK9 VHH Single Domain Antibody (PKE2) | FuncS, Inhib, FC, WB | Single domain antibody |
TAB-0081CL-VHH | Anti-Human PCSK9 VHH Single Domain Antibody (PKF8) | FuncS, Inhib, FC, WB | Single domain antibody |
TAB-0082CL-VHH | Anti-Human PCSK9 VHH Single Domain Antibody (PKG1) | FuncS, Inhib, FC, WB | Single domain antibody |
TAB-0083CL-VHH | Anti-Human PCSK9 VHH Single Domain Antibody (P1.70) | FuncS, Inhib, FC, WB | Single domain antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-H10 | Anti-Human PCSK9 Recombinant Antibody (Bococizumab) | WB, FC, IP, ELISA, Neut, FuncS, IF | IgG2 - kappa |
TAB-H59 | Anti-Human PCSK9 Recombinant Antibody (Ralpancizumab) | Neut, ELISA, IF, IP, FuncS, FC, ICC | IgG2 - kappa |
TAB-764CL | Human Anti-PCSK9 Recombinant Antibody (TAB-764CL) | ELISA | Human IgG |
TAB-0020CL | Anti-Human PCSK9 Recombinant Antibody (LPD1282/LPD1462 {i.e., antibody 1 F11)) | LDL-c uptake assay | Humanized Antibody |
TAB-0020CL-S(P) | Anti-Human PCSK9 Recombinant Antibody scFv Fragment (LPD1282/LPD1462 {i.e., antibody 1 F11)) | LDL-c uptake assay | Humanized Antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-294 | Human Anti-PCSK9 Recombinant Antibody (clone mAb1); scFv Fragment | WB, Block, FuncS | Human scFv |
HPAB-1383-FY-F(E) | Mouse Anti-PCSK9 Recombinant Antibody; Fab Fragment (HPAB-1383-FY-F(E)) | Block, Inhib | Mouse Fab |
HPAB-0511-FY-S(P) | Human Anti-PCSK9 Recombinant Antibody; scFv Fragment (HPAB-0511-FY-S(P)) | Neut | Human scFv |
HPAB-0512-FY-S(P) | Human Anti-PCSK9 Recombinant Antibody; scFv Fragment (HPAB-0512-FY-S(P)) | Neut | Human scFv |
HPAB-0513-FY-S(P) | Human Anti-PCSK9 Recombinant Antibody; scFv Fragment (HPAB-0513-FY-S(P)) | Neut | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBL-670 | Human Anti-PCSK9 Recombinant Antibody; Fab Fragment (PFBL-670) | WB, FuncS | Human Fab |
PFBL-671 | Mouse Anti-PCSK9 Recombinant Antibody (clone mAb J16); Fab Fragment | WB, ELISA, FuncS | Mouse Fab |
PFBL-672 | Human Anti-PCSK9 Recombinant Antibody (clone CBL36Q); Fab Fragment | ELISA, WB | Human Fab |
HPAB-667-FY-F(E) | Human Anti-PCSK9 Recombinant Antibody; Fab Fragment (HPAB-667-FY-F(E)) | Inhib | Human Fab |
HPAB-668-FY-F(E) | Human Anti-PCSK9 Recombinant Antibody; Fab Fragment (HPAB-668-FY-F(E)) | Inhib | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0953CL | Human Anti-PCSK9 Recombinant Antibody (TAB-0953CL) | ELISA | Human IgG1 |
TAB-0954CL | Human Anti-PCSK9 Recombinant Antibody (TAB-0954CL) | WB | Human IgG |
TAB-0955CL | Mouse Anti-PCSK9 Recombinant Antibody (TAB-0955CL) | WB | Mouse IgG |
TAB-0959CL | Human Anti-PCSK9 Recombinant Antibody (TAB-0959CL) | ELISA, FC | Human antibody |
TAB-0959CL-S(P) | Human Anti-PCSK9 Recombinant Antibody; scFv Fragment (TAB-0959CL-S(P)) | ELISA, FC | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0956CL | Anti-Human PCSK9 Recombinant Antibody (m7F8) | ELISA | |
TAB-0956CL-S(P) | Anti-Human PCSK9 Recombinant Antibody scFv Fragment (m7F8) | ELISA | |
TAB-0960CL-S(P) | Anti-Human PCSK9 Recombinant Antibody scFv Fragment (Ab1) | ELISA | Rabbit mAb |
TAB-0956CL-F(E) | Anti-Human PCSK9 Recombinant Antibody Fab Fragment (m7F8) | ELISA | |
TAB-0960CL-F(E) | Anti-Human PCSK9 Recombinant Antibody Fab Fragment (Ab1) | ELISA | Rabbit mAb |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1826CQ | Recombinant Human Anti-PCSK9 Antibody, Unconjugated | Neut | IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-2618 | Hi-Affi™ Recombinant Rabbit Anti-PCSK9 Monoclonal Antibody (DS2618AB) | WB | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-758 | Afuco™ Anti-PCSK9 ADCC Recombinant Antibody (Lodelcizumab), ADCC Enhanced | ELISA, FC, IP, FuncS, IF, Neut | ADCC enhanced antibody |
AFC-TAB-H10 | Afuco™ Anti-PCSK9 ADCC Recombinant Antibody (Bococizumab), ADCC Enhanced | FC, IP, ELISA, Neut, FuncS | ADCC enhanced antibody |
AFC-TAB-H59 | Afuco™ Anti-PCSK9 ADCC Recombinant Antibody (Ralpancizumab), ADCC Enhanced | Neut, ELISA, IF, IP, FuncS, FC | ADCC enhanced antibody |
AFC-TAB-H31 | Afuco™ Anti-PCSK9 Recombinant Antibody (AFC-TAB-H31), ADCC Enhanced | FC, IP, ELISA, Neut, FuncS, IF | Human IgG1, λ |
There are currently no Customer reviews or questions for TAB-0958CL-S(P). Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.